Skip to main content
. 2023 Aug 4;2023(8):CD013573. doi: 10.1002/14651858.CD013573.pub2

Comparison 4. Anticoagulant agent versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
4.1 Major bleeding 1   Risk Ratio (IV, Random, 95% CI) Totals not selected
4.2 Adverse events 1 919 Risk Ratio (IV, Random, 95% CI) 0.89 [0.81, 0.99]